This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Skip to main content
Emergency appeal
The US pause on foreign aid puts lifesaving programs at risk. We need your help.
GIVE NOW
Donate
  • What we do
    • Back
    • What we do
    • Product development and access
      • Back
      • Product development and access
      • Devices
      • Diagnostics
      • Vaccines
      • Market shaping
      • Search
      • Donate
    • Health and disease management
      • Back
      • Health and disease management
      • Maternal, newborn, and child health
      • Noncommunicable diseases
      • Primary health care
      • Sexual and reproductive health
      • Infectious diseases
      • Search
      • Donate
    • Health systems strengthening
      • Back
      • Health systems strengthening
      • Advocacy and policy
      • Digital and data transformation
      • Human-centered design
      • Epidemic preparedness and response
      • Search
      • Donate
    • Search
    • Donate
  • Where we work
    • Back
    • Where we work
    • Africa
      • Back
      • Africa
      • Democratic Republic of the Congo
      • Ethiopia
      • Kenya
      • Senegal
      • See all...
      • Search
      • Donate
    • Asia-Pacific
      • Back
      • Asia-Pacific
      • Cambodia
      • China
      • India
      • Myanmar
      • See all...
      • Search
      • Donate
    • Americas
      • Back
      • Americas
      • United States
      • Latin America
      • Search
      • Donate
    • Europe
      • Back
      • Europe
      • Belgium
      • Switzerland
      • Ukraine
      • United Kingdom
      • Search
      • Donate
    • Search
    • Donate
  • Who we are
    • Back
    • Who we are
    • Mission and values
    • Leadership
    • Finances
    • Annual report
    • Code of ethics
    • Careers
    • Contact us
    • Programs
    • Featured

      PATH Strategy 2025: Year 3

      A progress update on our five-year institutional strategy.

    • Search
    • Donate
  • Our impact
    • Back
    • Our impact
    • Articles
    • Case studies
    • Events and conferences
    • Media center
    • Research and journal articles
    • Resources
    • Featured

      UHC by 2030

      Universal health coverage (UHC) is for everyone.

      2023 annual report

    • Search
    • Donate
  • Get involved
    • Back
    • Get involved
    • Individual donors fuel our impact
      • Back
      • Individual donors fuel our impact
      • Our pledge to donors
      • Donating stocks to PATH
      • Workplace giving and skill sharing
      • Planned giving
      • Search
      • Donate
    • Featured

      Corporate partners

      High-impact corporate partnerships are essential to global health progress. At PATH, we partner with corporations that are innovative, bold, and focused on impact.

      Global partners

      We are the partner of choice to many of the world's leading governments, multilaterals, and institutional foundations.

    • Search
    • Donate
  • Search
  • Donate
What we do Where we work Who we are Our impact Get involved
What we do
  • Product development and access
  • Devices
  • Diagnostics
  • Vaccines
  • Market shaping
  • Health and disease management
  • Maternal, newborn, and child health
  • Noncommunicable diseases
  • Primary health care
  • Sexual and reproductive health
  • Infectious diseases
  • Health systems strengthening
  • Advocacy and policy
  • Digital and data transformation
  • Human-centered design
  • Epidemic preparedness and response
Where we work
  • Africa
  • Democratic Republic of the Congo
  • Ethiopia
  • Kenya
  • Senegal
  • See all...
  • Asia-Pacific
  • Cambodia
  • China
  • India
  • Myanmar
  • See all...
  • Americas
  • United States
  • Latin America
  • Europe
  • Belgium
  • Switzerland
  • Ukraine
  • United Kingdom
Who we are
  • Mission and values
  • Leadership
  • Finances
  • Annual report
  • Code of ethics
  • Careers
  • Contact us
  • Programs

Featured

PATH Strategy 2025: Year 3

A progress update on our five-year institutional strategy.

Our impact
  • Articles
  • Case studies
  • Events and conferences
  • Media center
  • Research and journal articles
  • Resources

Featured

UHC by 2030

Universal health coverage (UHC) is for everyone.

2023 annual report

Get involved
  • Individual donors fuel our impact
  • Our pledge to donors
  • Donating stocks to PATH
  • Workplace giving and skill sharing
  • Planned giving

Featured

Corporate partners

High-impact corporate partnerships are essential to global health progress. At PATH, we partner with corporations that are innovative, bold, and focused on impact.

Global partners

We are the partner of choice to many of the world's leading governments, multilaterals, and institutional foundations.

Developing Materials on HIV/AIDS/STIs for Low-Literate Audiences: A Guide

This publication is a comprehensive discussion of developing print materials for programs to use to reduce the incidence of sexually transmitted infections, including HIV. It is available for downloading as one large file or as five smaller files.

Corporate author(s): PATH; FHI360; USAID

Publication date: January 2002

Available materials

    1. Developing Materials on HIV/AIDS/STIs for Low-Literate Audiences Entire Manual 2.6 MB PDF

    2. Developing Materials on HIV/AIDS/STIs for Low-Literate Audiences: Section 1: Acknowledgements, Table of Contents, and List of Figures - PDF

    3. Developing Materials on HIV/AIDS/STIs for Low-Literate Audiences: Section 2: Chapter I (Introduction), Chapter II (Target Populations), Chapter III (Audience Research), and Chapter IV (Message Development and Design) - PDF

    4. Developing Materials on HIV/AIDS/STIs for Low-Literate Audiences: Section 3: Chapter V (Key Concepts for HIV/AIDS/STI Programs), Chapter VI (Guidelines for Materials Production), and Chapter VII (Pretesting and Revision) - PDF

    5. Developing Materials on HIV/AIDS/STIs for Low-Literate Audiences: Section 4: Chapter VII (Pretesting and Revision), Chapter IX (Training and Distribution), Chapter X (Evaluation), Chapter XI (Conclusion), Bibliography, Resources, and Glossary of Acronyms - PDF

    6. Developing Materials on HIV/AIDS/STIs for Low-Literate Audiences: Section 5: Appendices - PDF

Learn more about PATH's work

By submitting this form, you are agreeing to the data-use policies outlined in this privacy notice.

Thank you for signing up!

  • Instagram Instagram
  • Bluesky
  • Facebook
  • YouTube
  • LinkedIn

About Us

  • Overview
  • Leadership
  • Finances
  • Media Center
  • Careers
  • Code of Ethics
  • FAQ

Partner & Invest

  • Overview
  • For Individuals
  • For Corporations
  • For Global Partners

Contact Us

  • Overview
  • Stay informed
  • Instagram Instagram
  • Bluesky
  • Facebook
  • YouTube
  • LinkedIn
  • Ⓒ 2025 PATH
  • Terms of Use
  • Copyright Policy
  • Privacy Notice
  • Requests for Proposals